Diabetes in Cardiovascular Disease: A Companion to Braunwald's Heart Disease E-BookDiabetes in Cardiovascular Disease is a current, expert resource focusing on the complex challenges of providing cardiovascular care to patients with diabetes. Designed as a companion to Braunwald’s Heart Disease, this interdisciplinary medical reference book bridges the gap between the cardiology and endocrinology communities of scientists and care providers, and highlights the emerging scientific and clinical topics that are relevant for cardiologists, diabetologists/endocrinologists, and the extended diabetes care team.
|
Contents
1 | |
10 | |
Type 1 Diabetes | 24 |
The Metabolic Syndrome | 37 |
Lifestyle Interventions for the Prevention of Type 2 Diabetes Mellitus | 44 |
Pharmacologic and Surgical Interventions That Prevent or Worsen Type 2 Diabetes | 57 |
Diabetes and Atherosclerosis | 73 |
Pathology of Diabetic Atherosclerosis | 87 |
Role of Coronary Artery Bypass Surgery in Diabetes and Perioperative Glucose Management | 228 |
Epidemiology and Management of Acute Coronary Syndromes in Patients with Diabetes | 239 |
Hyperglycemia and Acute Coronary Syndromes | 251 |
Antiplatelet and Antithrombotic Therapy in Diabetic Patients with Acute Coronary Syndrome | 262 |
Role of Primary Invasive Strategy and Revascularization in Diabetic Patients with Acute Coronary Syndromes | 271 |
Heart Failure in Diabetes | 281 |
Diabetic Cardiomyopathy | 290 |
Prevention of Heart Failure in Patients with Diabetes | 302 |
Vascular Biology of Atherosclerosis in Patients with Diabetes | 99 |
Vascular Biology of Atherosclerosis in Patients with Diabetes | 111 |
Type 1 Diabetes and Associated Cardiovascular Risk and Disease | 127 |
Management of Coronary Heart Disease Risk and Disease in Patients with Diabetes | 139 |
Effect of Glucose Management on Coronary Heart Disease Risk in Patients with Diabetes | 155 |
Effect of Blood Pressure Management on Coronary Heart Disease Risk in Patients with Type 2 Diabetes | 171 |
Effect of Lipid Management on Coronary Heart Disease Risk in Patients with Diabetes | 181 |
Effect of Antiplatelet Therapy on Coronary Heart Disease Risk in Patients with Diabetes Mellitus | 203 |
Role of Percutaneous Coronary Intervention in Patients with Diabetes | 217 |
Treatment of Heart Failure in Diabetes Systolic Dysfunction Diastolic Dysfunction and PostAcute Coronary | 313 |
Other Diabetesrelated Cardiovascular Considerations | 329 |
Cerebrovascular Disease in Patients with Diabetes | 341 |
Cardiovascular Autonomic Neuropathy | 361 |
Disparities in Diabetes Risk Cardiovascular Consequences and Care | 369 |
The Quality Chasm | 379 |
385 | |
Inside Back Cover | 399 |
Common terms and phrases
activity addition adults American analysis artery disease aspirin associated atherosclerosis benefit beta blood CABG cardiac Cardiol cardiovascular cardiovascular disease cells changes cholesterol Circulation clinical clopidogrel compared complications coronary artery death decreased diabetes mellitus diabetic patients disease dysfunction effects elevated et al evidence exercise factors function glucose glycemic greater HbA1c heart failure higher hospitalization hyperglycemia hypertension impaired important improved incidence increased individuals inhibitors insulin resistance intensive Intern intervention levels lifestyle lipid lower major metabolic mg/dL mortality myocardial infarction obesity observed outcomes patients with diabetes patients with type platelet population prevalence prevention primary protein randomized recent receptor reduced reported response revascularization risk risk factors role showed significant statin stents strategies stroke suggest syndrome T2DM therapy tion treated treatment trial type 2 diabetes vascular versus weight women